Glaukos Gross Profit 2014-2026 | GKOS
Glaukos annual/quarterly gross profit history and growth rate from 2014 to 2026. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- Glaukos gross profit for the quarter ending June 30, 2026 was $0.152B, a 55.92% increase year-over-year.
- Glaukos gross profit for the twelve months ending June 30, 2026 was $0.485B, a 46.7% increase year-over-year.
- Glaukos annual gross profit for 2025 was $0.396B, a 36.68% increase from 2024.
- Glaukos annual gross profit for 2024 was $0.289B, a 21.04% increase from 2023.
- Glaukos annual gross profit for 2023 was $0.239B, a 11.81% increase from 2022.
|
Glaukos Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2025 | $396 |
| 2024 | $289 |
| 2023 | $239 |
| 2022 | $214 |
| 2021 | $227 |
| 2020 | $133 |
| 2019 | $198 |
| 2018 | $156 |
| 2017 | $138 |
| 2016 | $98 |
| 2015 | $59 |
| 2014 | $34 |
| 2013 | $18 |
|
Glaukos Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2026-06-30 | $152 |
| 2026-03-31 | $117 |
| 2025-12-31 | $111 |
| 2025-09-30 | $105 |
| 2025-06-30 | $97 |
| 2025-03-31 | $82 |
| 2024-12-31 | $77 |
| 2024-09-30 | $74 |
| 2024-06-30 | $73 |
| 2024-03-31 | $65 |
| 2023-12-31 | $63 |
| 2023-09-30 | $60 |
| 2023-06-30 | $60 |
| 2023-03-31 | $56 |
| 2022-12-31 | $54 |
| 2022-09-30 | $54 |
| 2022-06-30 | $55 |
| 2022-03-31 | $51 |
| 2021-12-31 | $56 |
| 2021-09-30 | $59 |
| 2021-06-30 | $60 |
| 2021-03-31 | $51 |
| 2020-12-31 | $54 |
| 2020-09-30 | $47 |
| 2020-06-30 | $10 |
| 2020-03-31 | $23 |
| 2019-12-31 | $50 |
| 2019-09-30 | $51 |
| 2019-06-30 | $51 |
| 2019-03-31 | $47 |
| 2018-12-31 | $47 |
| 2018-09-30 | $38 |
| 2018-06-30 | $37 |
| 2018-03-31 | $34 |
| 2017-12-31 | $37 |
| 2017-09-30 | $35 |
| 2017-06-30 | $36 |
| 2017-03-31 | $31 |
| 2016-12-31 | $28 |
| 2016-09-30 | $26 |
| 2016-06-30 | $24 |
| 2016-03-31 | $20 |
| 2015-12-31 | $17 |
| 2015-09-30 | $16 |
| 2015-06-30 | $14 |
| 2015-03-31 | $12 |
| 2014-12-31 | $9 |
| 2014-09-30 | $10 |
| 2014-06-30 | $9 |
| 2014-03-31 | $6 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $10.092B | $0.507B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $226.884B | 25.75 |
| Intuitive Surgical (ISRG) | United States | $133.518B | 45.26 |
| Edwards Lifesciences (EW) | United States | $49.242B | 30.43 |
| IQVIA Holdings (IQV) | United States | $43.729B | 23.39 |
| Waters (WAT) | United States | $40.283B | 29.97 |
| IDEXX Laboratories (IDXX) | United States | $40.144B | 35.83 |
| Alcon (ALC) | Switzerland | $33.505B | 20.78 |
| DexCom (DXCM) | United States | $31.955B | 33.21 |
| Mettler-Toledo (MTD) | United States | $25.762B | 28.65 |
| STERIS (STE) | Ireland | $20.832B | 20.50 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.759B | 0.00 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| Coloplast (CLPBY) | Denmark | $14.762B | 17.70 |
| Penumbra (PEN) | United States | $12.599B | 83.08 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.279B | 8.59 |
| Globus Medical (GMED) | United States | $10.173B | 15.40 |
| Masimo (MASI) | United States | $9.578B | 30.69 |
| SARTORIUS (SSSGY) | Germany | $7.521B | 43.67 |
| Sysmex ADR (SSMXY) | Japan | $7.390B | 27.95 |
| Teleflex (TFX) | United States | $5.521B | 14.89 |
| LivaNova (LIVN) | United Kingdom | $4.442B | 22.46 |
| Integer Holdings (ITGR) | United States | $4.287B | 19.86 |
| Pulse Biosciences (PLSE) | United States | $3.752B | 0.00 |
| Veracyte (VCYT) | United States | $3.313B | 27.11 |
| TransMedics (TMDX) | United States | $2.967B | 43.58 |
| AxoGen (AXGN) | United States | $2.354B | 0.00 |
| UFP Technologies (UFPT) | United States | $2.153B | 27.17 |
| Elekta AB (EKTAY) | Sweden | $1.883B | 17.62 |
| Nihon Kohden (NHNKY) | Japan | $1.694B | 15.52 |
| Alphatec Holdings (ATEC) | United States | $1.677B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $1.301B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.222B | 6.36 |
| Artivion (AORT) | United States | $1.217B | 46.24 |
| PROCEPT BioRobotics (PRCT) | United States | $1.204B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.171B | 27.77 |
| Tandem Diabetes Care (TNDM) | United States | $1.170B | 0.00 |
| OPKO Health (OPK) | United States | $1.164B | 0.00 |
| IRadimed (IRMD) | United States | $1.055B | 46.11 |
| Anteris Technologies Global (AVR) | Australia | $0.850B | 0.00 |
| SiBone (SIBN) | United States | $0.829B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.753B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.680B | 16.37 |
| AngioDynamics (ANGO) | United States | $0.641B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.583B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.570B | 1644.00 |
| Tactile Systems Technology (TCMD) | United States | $0.511B | 20.90 |
| NeuroPace (NPCE) | United States | $0.501B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.448B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.420B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.411B | 0.00 |
| 908 Devices (MASS) | United States | $0.402B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.371B | 0.00 |
| Mobia Medical (MOBI) | United States | $0.334B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Treace Medical Concepts (TMCI) | United States | $0.301B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.266B | 0.00 |
| RxSight (RXST) | United States | $0.254B | 0.00 |
| Neuronetics (STIM) | United States | $0.221B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.159B | 0.00 |
| FocalTherics (FOCL) | France | $0.154B | 0.00 |
| Inogen (INGN) | United States | $0.139B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.124B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| LENSAR (LNSR) | United States | $0.096B | 0.00 |
| Hyperfine (HYPR) | United States | $0.085B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.083B | 0.00 |
| CVRx (CVRX) | United States | $0.080B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.071B | 23.27 |
| DarioHealth (DRIO) | United States | $0.069B | 0.00 |
| Positron (POSC) | United States | $0.059B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.059B | 0.00 |
| Envoy Medical (COCH) | United States | $0.056B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.055B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.052B | 0.00 |
| Precision Optics (POCI) | United States | $0.048B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.045B | 0.00 | |
| InspireMD (NSPR) | United States | $0.038B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.036B | 0.00 |
| PAVmed (PAVM) | United States | $0.035B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.032B | 0.00 |
| Accuray (ARAY) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.010B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| NexGel (NXGL) | United States | $0.003B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.000B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |